Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

H Yoshiji, S Nagoshi, T Akahane, Y Asaoka… - Journal of …, 2021 - Springer
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …

Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis

G Kim, SH Kang, MY Kim, SK Baik - PloS one, 2017 - journals.plos.org
Background Sarcopenia is a common syndrome in chronic diseases such as liver cirrhosis.
The association between sarcopenia and outcomes, such as complications and survival has …

Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association …

SW Biggins, P Angeli, G Garcia‐Tsao, P Ginès… - …, 2021 - Wiley Online Library
This AASLD Guidance provides a data-supported approach to the management of ascites
and HRS. It differs from the AASLD Guidelines, which are supported by systematic reviews …

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

European Association For The Study Of … - Journal of …, 2010 - journal-of-hepatology.eu
Ascites is the most common complication of cirrhosis, and 60% of patients with compensated
cirrhosis develop ascites within 10 years during the course of their disease [1]. Ascites only …

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

G D'Amico, G Garcia-Tsao… - Journal of …, 2006 - journal-of-hepatology.eu
1. Background Liver transplantation significantly improves the survival and quality of life of
patients with end-stage cirrhosis. However, a large proportion of cirrhotic patients still die …

[PDF][PDF] The model for end‐stage liver disease (MELD)

PS Kamath, WR Kim - Hepatology, 2007 - Wiley Online Library
Abstract The Model for End‐stage Liver Disease (MELD) was initially created to predict
survival in patients with complications of portal hypertension undergoing elective placement …

Hyponatremia and mortality among patients on the liver-transplant waiting list

WR Kim, SW Biggins, WK Kremers… - … England Journal of …, 2008 - Mass Medical Soc
Background Under the current liver-transplantation policy, donor organs are offered to
patients with the highest risk of death. Methods Using data derived from all adult candidates …

Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography

F Durand, S Buyse, C Francoz, C Laouénan… - Journal of …, 2014 - Elsevier
Background & Aims Waiting-list mortality in patients with cirrhosis and a relatively low MELD
score is a matter of concern. The aim of this study was to determine whether a marker of …

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial

E Solà, C Solé, M Simón-Talero, M Martín-Llahí… - Journal of …, 2018 - Elsevier
Background & Aims Patients with decompensated cirrhosis on the waiting list for liver
transplantation (LT) commonly develop complications that may preclude them from reaching …